Summary
We clarified the clinical features of NICCD (neonatal intrahepatic cholestasis caused by citrin deficiency) by retrospective review of symptoms, management and long-term outcome of 75 patients. The data were generated from questionnaires to paediatricians in charge of the patients. Thirty of the patients were referred to hospitals before 1 month of age because of positive results in newborn screening (hypergalactosaemia, hypermethioninaemia, and hyperphenylalaninaemia). The other 45, the screen-negative patients, were referred to hospitals with suspected neonatal hepatitis or biliary atresia because of jaundice or discoloured stool. Most of the screen-negative patients presented before 4 months of age, and 11 had failure to thrive. Laboratory data showed elevated serum bile acid concentrations, hypoproteinaemia, low levels of vitamin K-dependent coagulation factors and hypergalactosaemia. Hypoglycaemia was detected in 18 patients. Serum amino acid analyses showed significant elevation of citrulline and methionine concentrations. Most of the patients were given a lactose-free and/or medium-chain triglyceride-enriched formula and fat-soluble vitamins. Symptoms resolved in all but two of the patients by 12 months of age. The two patients with unresolved symptoms suffered from progressive liver failure and underwent liver transplantation before their first birthday. Another patient developed citrullinaemia type II (CTLN2) at age 16 years. It is important to recognize that NICCD is not always a benign condition.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Abbreviations
- CTLN2:
-
citrullinaemia type 2
- NICCD:
-
neonatal intrahepatic cholestasis caused by citrin deficiency
References
Balistreri WF (1985) Neonatal cholestasis. J Pediatr 106: 171–186.
Ben-Shalom E, Kobayashi K, Shaag A, et al (2002) Infantile citrullinemia caused by citrin deficiency with increased dibasic amino acids. Mol Genet Metab 77: 202–208.
Hachisu M, Oda Y, Goto M, et al (2005) Citrin deficiency presenting with ketotic hypoglycaemia and hepatomegaly in childhood. Eur J Pediatr 164: 109–110.
Imamura Y, Kobayashi K, Shibatou T, et al (2003) Effectiveness of carbohydrate-restricted diet and arginine granules therapy for adult-onset type II citrullinemia: a case report of siblings showing homozygous SLC25A13 mutation with and without the disease. Hepatol Res 26: 68–72.
Kobayashi K, Shaheen N, Kumashiro R, et al (1993) A search for the primary abnormality in adult-onset type II citrullinemia. Am J Hum Genet 53: 1024–1030.
Kobayashi K, Horiuchi M, Saheki T (1997) Pancreatic secretory trypsin inhibitor as a diagnostic marker for adult-onset type II citrullinemia. Hepatology 25: 1160–1165.
Kobayashi K, Sinasac DS, Iijima M, et al (1999) The gene mutated in adult-onset type II citrullinaemia encodes a putative mitochondrial carrier protein. Nat Genet 22: 159–163.
Kobayashi K, Lu YB, Li MX, et al (2003) Screening of nine SLC25A13 mutations: their frequency in patients with citrin deficiency and high carrier rates in Asian populations. Mol Genet Metab 80: 356–359.
Lee J, Ellaway C, Kobayashi K, Wilcken B (2002) Citrullinaemia type II: a rare cause of neonatal hepatitis detected by newborn screening. J Inherit Metab Dis 25 (Supplement 1): 29.
Lu YB, Kobayashi K, Ushikai M, et al (2005) Frequency and distribution in East Asia of 12 mutations identified in the SLC25A13 gene of Japanese patients with citrin deficiency. J Hum Genet 50: 338–346.
Naito E, Ito I, Matsuura S, et al (2002) Type II citrullinaemia (citrin deficiency) in a neonate with hypergalactosaemia detected by mass screening. J Inherit Metab Dis 25: 71–76.
Ohura T, Kobayashi K, Tazawa Y, et al (2001) Neonatal presentation of adult-onset type II citrullinemia. Hum Genet 108: 87–90.
Ohura T, Kobayashi K, Abukawa D, et al (2003) A novel inborn error of metabolism detected by elevated methionine and/or galactose in newborn screening: neonatal intrahepatic cholestasis caused by citrin deficiency. Eur J Pediatr 162: 317–322.
Palmieri L, Pardo B, Lasorsa FM, et al (2001) Citrin and aralar1 are Ca2+-stimulated aspartate/glutamate transporters in mitochondria. EMBO J 20: 5060–5069.
Saheki T, Kobayashi K (2002) Mitochondrial aspartate glutamate carrier (citrin) deficiency as the cause of adult-onset type II citrullinemia (CTLN2) and idiopathic neonatal hepatitis (NICCD). J Hum Genet 47: 333–341.
Saheki T, Kobayashi K, Inoue I, et al (1987), Hereditary disorders of the urea cycle in man: biochemical and molecular approaches. Rev Physiol Biochem Pharmacol 108: 21–68.
Shigematsu Y, Hirano S, Hata I, et al (2002) Newborn mass screening and selective screening using electrospray tandem mass spectrometry in Japan. J Chromatogr B 776: 39–48.
Tamamori A, Okano Y, Ozaki H (2002) Neonatal intrahepatic cholestasis caused by citrin deficiency: severe hepatic dysfunction in an infant requiring liver transplantation. Eur J Pediatr 161: 609–613.
Tamamori A, Fujimoto A, Okano Y, et al (2004) Effects of citrin deficiency in the perinatal period: feasibility of newborn mass screening for citrin deficiency. Pediatr Res 56: 608–614.
Tanaka T, Nagao M, Tsutsumi H, et al (2002) Application of mutation analysis for the previously uncertain cases of adult-onset type II citrullinemia (CTLN2) and their clinical profiles. Tohoku J Exp Med 198: 89–97.
Tazawa T, Kobayashi K, Ohura T, et al (2001) Infantile cholestatic jaundice associated with adult-onset type II citrullinemia. J Pediatr 138: 735–740.
Tazawa Y, Kobayashi K, Abukawa D, et al (2004) Clinical heterogeneity of neonatal intrahepatic cholestasis caused by citrin deficiency: case reports from 16 patients. Mol Genet Metab 83, 213–219.
Tomomasa T, Kobayashi K, Kaneko H, et al (2001) Possible clinical and histologic manifestations of adult-onset type II citrullinemia in early infancy. J Pediatr 138: 741–743.
Yamaguchi N, Kobayashi K, Yasuda T, et al (2002) Screening of SLC25A13 mutations in early and late onset patients with citrin deficiency and in the Japanese population: Identification of two novel mutations and establishment of multiple DNA diagnosis methods for nine mutations. Hum Mutat 19: 122–130.
Yasuda T, Yamaguchi N, Kobayashi K, et al (2000) Identification of two novel mutations in the SLC25A13 gene and detection of seven mutations in 102 patients with adult-onset type II citrullinemia. Hum Genet 107, 537–45.
Author information
Authors and Affiliations
Corresponding author
Additional information
Communicating editor: Verena Peters
Competing interests: None declared
References to electronic databases: CTLN2, OMIM #603471; NICCD, OMIM #605814
Rights and permissions
About this article
Cite this article
Ohura, T., Kobayashi, K., Tazawa, Y. et al. Clinical pictures of 75 patients with neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD). J Inherit Metab Dis 30, 139–144 (2007). https://doi.org/10.1007/s10545-007-0506-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10545-007-0506-1